#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biotinidase deficiency Warm autoimmune haemolytic anaemia Cholestatic pruritus Acute graft versus host disease in skin Choroid melanoma Monogenic diabetes Mantle cell lymphoma stage III Plasma cell myeloma Leukaemia Bronchiolitis B-cell lymphoma refractory Adrenoleukodystrophy Follicular lymphoma stage II Acquired haemophilia Infantile spasms More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Basic Information Mantle cell lymphoma refractory – Life with Disease Haemophagocytic lymphohistiocytosis – Treatment Immunodeficiency congenital Mantle cell lymphoma – Life with Disease Myelodysplastic syndrome – Treatment Ehlers-Danlos syndrome – Basic Information Mantle cell lymphoma refractory – Diagnostics Acute respiratory distress syndrome – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Suxamethonium Chloride Bms-986449-03 Air, Medicinal Ofloxacin Deferoxamine Ucart20X22 Lithium Carbonate Cyclophosphamide ZILUCOPLAN Gskvx000000008866 Adenosine Tanimilast Lenvatinib Fexofenadine Hydrochloride Tasquinimod Anselamimab Sirolimus Azd5462 Mva-Hbvac Iodine (123I) Iobenguane More therapies…

    Learn about Your Condition

    Cardiomyopathy Lymphocytic lymphoma Dermatomyositis Gastrectomy Placenta praevia Tourette's disorder Iron deficiency anaemia Polymyositis Carotid artery occlusion Malignant neoplasm of choroid Congenital pseudarthrosis Skin papilloma Hypopituitarism Decreased appetite Niemann-Pick disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neuroblastoma

  • Study of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Edotreotide
    • Lutetium (177Lu) Oxodotreotide
    • L-Arginine Hydrochloride
    Denmark Lithuania The Netherlands Norway Spain Sweden

  • Study of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Irinotecan
    • Temozolomide
    Denmark France Germany Ireland Spain

  • Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ANTI-GD2-800CW
    The Netherlands

  • Study of ABTL0812 with Irinotecan and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Sodium 2-Hydroxylinoleate
    Spain

  • Study on the Safety of 68Ga-SATO and Iodine (123I) Iobenguane in Children with Neuroblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Satoreotide Trizoxetan Gallium (Ga68)
    The Netherlands

  • Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Clonazepam
    • Lenograstim
    • Dinutuximab Beta
    Germany
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!